CD53 and neoplasm: However, the CD53 antibody evoked a weak redirected inhibition of cytotoxicity towards the Fc-receptor+ NK sensitive tumor target P388D1 (Fig 3B, right panel), indicating that CD53 transduce signals that may negatively affect NK cytotoxicity.